000 01571 a2200433 4500
005 20250511232210.0
264 0 _c19910219
008 199102s 0 0 eng d
022 _a0303-7207
024 7 _a10.1016/0303-7207(90)90130-z
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDauvois, S
245 0 0 _aOpposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells.
_h[electronic resource]
260 _bMolecular and cellular endocrinology
_cOct 1990
300 _a171-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aApolipoproteins
650 0 4 _aApolipoproteins D
650 0 4 _aBreast Neoplasms
_xpathology
650 0 4 _aCarrier Proteins
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aDrug Interactions
650 0 4 _aEstradiol
_xpharmacology
650 0 4 _aFlutamide
_xanalogs & derivatives
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aGlycoproteins
650 0 4 _aHumans
650 0 4 _aMembrane Transport Proteins
650 0 4 _aMifepristone
_xpharmacology
650 0 4 _aNeoplasm Proteins
_xbiosynthesis
650 0 4 _aPromegestone
_xpharmacology
650 0 4 _aTumor Cells, Cultured
_xdrug effects
700 1 _aSimard, J
700 1 _aDumont, M
700 1 _aHaagensen, D E
700 1 _aLabrie, F
773 0 _tMolecular and cellular endocrinology
_gvol. 73
_gno. 2-3
_gp. 171-8
856 4 0 _uhttps://doi.org/10.1016/0303-7207(90)90130-z
_zAvailable from publisher's website
999 _c2275481
_d2275481